The Use of Complementary and Integrative Medicine in Combination With Pharmacological Antiemetics to Address Chemotherapy-Induced Nausea and Vomiting in Pediatric Oncology: A Scoping Review.

Madeleine Kajencki, Lucie Turcotte, Melissa Claar, Elizabeth V Weinfurter, Mary O Whipple
Author Information
  1. Madeleine Kajencki: Pediatric Hematology/Oncology and Bone Marrow Transplant, M Health Fairview Masonic Children's Hospital, Minneapolis, MN, USA. ORCID
  2. Lucie Turcotte: Division of Pediatric Hematology Oncology, M Health Fairview Masonic Children's Hospital, Minneapolis, MN, USA.
  3. Melissa Claar: Pediatric Integrative Health & Wellbeing, M Health Fairview Masonic Children's Hospital, Minneapolis, MN, USA.
  4. Elizabeth V Weinfurter: Health Sciences Library, University of Minnesota, Minneapolis, MN, USA.
  5. Mary O Whipple: Adult and Gerontological Health Cooperative, School of Nursing, University of Minnesota, Minneapolis, MN, USA. ORCID

Abstract

Chemotherapy is a common treatment in childhood cancer but causes significant side effects, among the most notable being nausea and vomiting, known as chemotherapy-induced nausea and vomiting (CINV). Pharmacological antiemetics and complementary and integrative medicine (CIM) have been studied separately to manage CINV, but a gap exists in understanding their use together. We aimed to investigate the potential multimodal effects of CIM and pharmacological antiemetics on CINV in pediatric oncology patients undergoing chemotherapy. Systematic searches were conducted in four databases to identify studies evaluating the efficacy of CIM in combination with pharmacological antiemetics in patients ages 0-21 with cancer undergoing chemotherapy. Relevant data were extracted from each study and evaluated. Eighteen sources examining CIM therapies in three distinct categories (herbal, physical, and psychological) were identified. Three of four herbal interventions yielded significant results, all of which implemented oral ginger. Physical interventions included manual and wristband acupressure, auricular acupuncture, and needle and laser acupuncture. Significant results were found in only four of these 10 studies. Among psychological interventions, two of four yielded significant results. There is no clear evidence of benefit from CIM therapies in addition to pharmacological antiemetics to better control CINV. However, this review provides support and direction for future research to examine potential effects. Complementary therapies generally have little potential for harm, are relatively low cost, and low burden. Therefore, if there is a perceived benefit for patients and families, complementary and integrative therapies should be considered.

Keywords

References

  1. J Pediatr Gastroenterol Nutr. 2019 Apr;68(4):466-471 [PMID: 30540713]
  2. Pediatr Blood Cancer. 2019 May;66(5):e27646 [PMID: 30729654]
  3. Eur J Oncol Nurs. 2022 Dec;61:102233 [PMID: 36401916]
  4. Children (Basel). 2018 Aug 20;5(8): [PMID: 30127308]
  5. Klin Padiatr. 2008 Nov-Dec;220(6):365-70 [PMID: 18949672]
  6. Paediatr Drugs. 2003;5(9):597-613 [PMID: 12956617]
  7. J Pediatr Oncol Nurs. 2018 Nov/Dec;35(6):392-398 [PMID: 29947285]
  8. BMC Complement Med Ther. 2022 Apr 2;22(1):97 [PMID: 35366871]
  9. Ann Intern Med. 2018 Oct 2;169(7):467-473 [PMID: 30178033]
  10. Pediatr Blood Cancer. 2011 Feb;56(2):234-8 [PMID: 20842754]
  11. J Int Med Res. 2018 Jun;46(6):2149-2156 [PMID: 29690798]
  12. Cancer. 2018 Mar 15;124(6):1188-1196 [PMID: 29266260]
  13. J Pediatr Oncol Nurs. 2017 May/Jun;34(3):173-184 [PMID: 28193133]
  14. J Soc Integr Oncol. 2008 Fall;6(4):141-5 [PMID: 19134445]
  15. Psychother Psychosom. 2015;84(6):339-47 [PMID: 26402426]
  16. Complement Ther Med. 2021 Aug;60:102730 [PMID: 34052340]
  17. J Pediatr Oncol Nurs. 2019 Jan/Feb;36(1):44-54 [PMID: 30798684]
  18. Cancer Nurs. 2025 Mar-Apr 01;48(2):89-98 [PMID: 37026978]
  19. J Pediatr Oncol Nurs. 2007 Jan-Feb;24(1):35-40 [PMID: 17185400]
  20. J Altern Complement Med. 2012 Apr;18(4):334-40 [PMID: 22515794]
  21. PLoS One. 2021 Oct 14;16(10):e0258514 [PMID: 34648568]
  22. Pediatr Neonatol. 2022 Jul;63(4):331-340 [PMID: 35314125]
  23. BMC Cancer. 2012 Sep 26;12:430 [PMID: 23009053]
  24. Cyberpsychol Behav. 1999;2(2):125-34 [PMID: 19178248]
  25. Support Care Cancer. 2006 Feb;14(2):172-6 [PMID: 16021478]
  26. Eur J Oncol Nurs. 2022 Jun;58:102121 [PMID: 35306247]
  27. Cochrane Database Syst Rev. 2016 Feb 02;2:CD007786 [PMID: 26836199]

Grants

  1. K12 AR084223/NIAMS NIH HHS

MeSH Term

Humans
Nausea
Vomiting
Antiemetics
Integrative Medicine
Child
Neoplasms
Complementary Therapies
Adolescent
Antineoplastic Agents
Child, Preschool
Female
Male
Young Adult
Infant

Chemicals

Antiemetics
Antineoplastic Agents

Word Cloud

Created with Highcharts 10.0.0CIMCINVantiemeticsfourtherapiescancersignificanteffectsnauseavomitingpotentialpharmacologicalpatientschemotherapyinterventionsresultsPharmacologicalcomplementaryintegrativepediatricundergoingstudiesherbalpsychologicalyieldedacupuncturebenefitComplementarylowChemotherapycommontreatmentchildhoodcausessideamongnotableknownchemotherapy-inducedmedicinestudiedseparatelymanagegapexistsunderstandingusetogetheraimedinvestigatemultimodaloncologySystematicsearchesconducteddatabasesidentifyevaluatingefficacycombinationages0-21RelevantdataextractedstudyevaluatedEighteensourcesexaminingthreedistinctcategoriesphysicalidentifiedThreeimplementedoralgingerPhysicalincludedmanualwristbandacupressureauricularneedlelaserSignificantfound10AmongtwoclearevidenceadditionbettercontrolHoweverreviewprovidessupportdirectionfutureresearchexaminegenerallylittleharmrelativelycostburdenThereforeperceivedfamiliesconsideredUseIntegrativeMedicineCombinationAntiemeticsAddressChemotherapy-InducedNauseaVomitingPediatricOncology:ScopingReview

Similar Articles

Cited By

No available data.